The Stakeholder Advocacy

Partner of the Academy of

Radiology Research

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

JUNE 24 EVENT — Medical Technology Exhibit
July 2010 By Renée Cruea
…………....
On June 24 the Coalition for Imaging tour can be found on page 7.
Advocate Staff
and Bioengineering Research With its membership continuing to
Renée L. Cruea, MPA (CIBR) co-sponsored a Medical increase, CIBR welcomes the follow-
President
Technology Exhibit with Representa- ing new members this month: Bio-
Editor in Chief
tive Edolphus Towns (D-NY). This technology Industry Organization,
Keith Kerneklian
Senior Editor event was the first of its kind within Fibroid Relief, and Parkinson’s Ac-
Virginia Lathrop the halls of Congress and provided tion Network (see page 8 for more
Editor not only a rare opportunity for CIBR, information). CIBR is eager to col-
……………….. but also a template for further devel- laborate with its newest members
Steering Committee opment of unique ways to educate with the aim of raising the profile of
William G. Bradley, Jr, MD, PhD
Members of Congress about imag- Former Democratic Leader Dick medical imaging to benefit patient
Chair, Department of Radiology
University of California, San Diego ing technology. Opening remarks Gephardt, Representative Ed Towns (D care. CIBR also welcomes new
CIBR Chair
were given by Representative -NY), and Renée Cruea (President, membership from those patient ad-
Steven Seltzer, MD
Chair, Department of Radiology Towns and former Democratic Lead- CIBR) make opening remarks. vocacy groups whose constituency
Brigham and Women’s Hospital
ARR President er Dick Gephardt. Several Members benefits from imaging technology to
Sholom Ackelsberg
of Congress and approximately 100 a CT scan), an Academic Radiolo- detect, diagnose, treat or manage
General Manager, Academic Re- Congressional staff attended this gist who spoke about current imag- diseases or conditions.
search Portfolio
GE Healthcare event. ing research and the value of imag-
Jim Beckett
Vice President, Clinical Research
ing, and an industry representative
Philips Medical Systems, N.A. who answered specific questions
R. Nick Bryan, MD, PhD about the modality itself.
Chair, Department of Radiology
University of Pennsylvania Health
System Additionally, CIBR is undertaking a
N. Reed Dunnick, MD
Chair, Department of Radiology
number of other educational initia-
University of Michigan Medical tives this year and looks forward to
Center
engaging its membership, interested
Daniel Garen
Vice President, Healthcare Policy legislative staff, and the health care
and Clinical Affairs
Siemens Healthcare
community in its efforts. On Sept. 21
Steven Haberlein CIBR will sponsor another tour at
Representative Vic Snyder (D-AR)
Vice President, Sales
the National Institutes of Health
FUJIFILM Medical Systems USA,
Representative Jesse Jackson, Jr. (D- speaks with CIBR leadership.
Inc. (NIH), to include the Clinical Center,
James Jorkasky IL) examines the Fuji 3D Digital Mam- and the National Institute of Biomed- Thanks again to the following CIBR
Executive Director mography display in 3D glasses. ical Imaging and Bioengineering members for making this event a
National Alliance for Eye and Vision
Research
(NIBIB). More information about the fantastic educational opportunity:
Michael Kalutkiewicz
Director of Government Affairs CIBR presented six out of ten dis- AdMeTech Foundation, C3: Colorec-
International & American Associa- play areas at the event, each focus- tal Cancer Coalition, Fibroid Relief,
tions for Dental Research
ing on a specific modality: CT, MR- FUJIFILM Medical Systems USA,
Richard Mather, PhD
Senior Manager, Clinical Programs guided Focused Ultrasound, PET, Inc., GE Healthcare, Lung Cancer
Toshiba Medical Research Institute
Mammography, Image Guided Inter- Alliance, Nuance Healthcare Divi-
Martha Nolan, JD
Vice President, Public Policy vention, and IT Decision Support. sion, Philips Medical Systems, N.A.,
Society for Women's Health Re-
search Each display area showcased tech- Siemens Healthcare, Society for
Lenny Reznik nology in a collaborative manner by Women’s Health Research, Toshiba
Director, Enterprise Imaging and
Information
including a patient advocate who Medical Research Institute, and
Agfa HealthCare Corporation was able to speak personally to the ZERO, as well as the following Radi-
Sheila Ross benefits of the modality (for exam- Laurie Fenton, CEO of Lung Cancer ology Departments: Brigham and
Special Counsel
ple, patient Melanie Smith who was Alliance, visits with CIBR leadership. Women’s Hospital, Emory Universi-
Lung Cancer Alliance

Paul Tuma diagnosed with lung cancer utilizing ty, University of California, San Die-
Regional Vice President go, and the University of Pennsylva-
Nuance Communications, Inc.
Nuance Healthcare Division
In this Issue nia.
…………………………
CIBR
1029 Vermont Avenue, NW, Suite 505
Medical Technology Event—Page 1 NIH-FDA Meeting—Page 5 Upcoming Events—Page 7
Washington, DC 20005 Photos and Feedback—Page 2-3 Fibroid Relief—Page 6 New Members—Page 8
Email: rcruea@imagingcoaliion.org
Radiation Exposure Initiative—Page 4 NIH Hearing—Page 7
Ph: 202.347.5872 Fax: 202.347.5876
 July 2010 Page 2

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

JUNE 24 EVENT — Photos of the Medical Technology Exhibit

Below: Dr. Steven Seltzer

(President, ARR), Renée
Cruea (President, CIBR),
Melanie Smith (Patient Advo-
cate, Lung Cancer Alliance),
Andrew Menard (Counsel, Rep. Ed Towns (D-NY), Former Demo- Former Democratic Leader Dick Gephardt Rep. Jesse Jackson, Jr. (D-IL)
CIBR), and Laurie Fenton cratic Leader Dick Gephardt, & Dr. speaks with Dr. Brad Wood of NIH, and discusses the imaging technology with
Ambrose (CEO, Lung Can- Carolyn Meltzer, Radiology Chair at CIBR leadership. CIBR leadership.
cer Alliance) at the Medical Emory University.
Technology Exhibit.

Right: CIBR leadership

meets with Rep. Ed
Towns (D-NY) in his
office on Capitol Hill to
discuss advances in
imaging technology.

―LCA was glad to have

been a part of this first-
ever forum – organized
specifically to educate Medical Technology Exhibit Feedback
policy makers on the
advancements and bene-
fits of imaging technolo- ―This was a wonderful opportunity for the members of CIBR to collaborate. The
gies in the early detec- interaction with Members of Congress and Congressional staff alone was worth
tion, diagnosis and treat- the participation.‖
ment of cancers and
other diseases. We ap- -William G. Bradley, Jr, MD, PhD
preciate that these tech- Chair, Department of Radiology, University of California San Diego
nologies can literally Chair, CIBR
mean the difference be-
tween life and "CIBR was honored to be invited by Rep. Towns to organize a medical imaging
death. Imaging is and will technology display. Each of CIBR's major constituents, including patient advocacy
remain an essential and groups, industry and academic radiologists were well represented at the event.
effective tool in the battle The event marked a major milestone for CIBR—the first time we had been invited
against lung cancer. I am by a Congressional leader to present an educational event to inform Members of
confident that the forum, Congress and their staff about the incredible impact that biomedical imaging has
with its real time displays had and will continue to have on the 21st century practice of medicine."
and patient testimonials,
made an impact on all -Steven E. Seltzer, MD
those able to attend.‖ Chair, Department of Radiology, Brigham and Women’s Hospital
President, Academy of Radiology Research
-Laurie Fenton Ambrose,
CEO, Lung Cancer Alliance
 July 2010 Page 3

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

JUNE 24 EVENT — Photos of the Medical Technology Exhibit

Former Democratic Leader Dick Gephardt Representative Jim Gerlach (R-PA) stops Former Democratic Leader Dick
is shown how MR-guided Focused Ultra- by the Siemens Healthcare PET display. Gephardt with CIBR President, Renée
sound is used to treat fibroids. Cruea.
―It was a pleasure to
have had the opportunity
to participate in the first-
ever Congressional Med-
ical Technology Exhibi-
tion on June 24th, 2010.
Medical innovation is key
to both economic growth
and improved treatment
and cures. The federal
government has an im-
portant role to play in CIBR members at the Fuji 3D Digital CIBR Chair Dr. Bill Bradley at the GE dis- Congressional staff view the Fuji 3D
Mammography display. play with Dr. Don Rucker of Siemens. Digital Mammography display.
developing policies to
promote and facilitate
medical innovation. Medical Technology Exhibit Feedback
I’m sure that enabling
―The exhibition was a unique and challenging opportunity to explain to Congressional representatives and their staff who we are
Members of Congress
and what we do in radiology. This event was a novel way to deliver our message.‖
and their staff to see -R. Nick Bryan, MD, PhD, Chair of Radiology, University of Pennsylvania School of Medicine
firsthand such an impres-
sive display of medical ―The opportunity for CIBR to show its face as collectively representing health advocacy and medical innovation was powerful. It
technology vividly under- was also an opportunity for radiology physician leaders and imaging device personnel to confront both common and divergent
scored the value of medi- goals in the current environment.‖
cal innovation and the -Carolyn C. Meltzer, MD, Chair of Radiology, Emory University School of Medicine
imperative to foster it.‖
"It was a pleasure for Fujifilm to participate in this inaugural event. We were excited by the enthusiasm of Members of Congress
-Former Democratic and their staff as they participated in the demonstration of our 3D Digital Mammography technology and look forward to attending
Leader Dick Gephardt, future events."
President & CEO, -Andrew F. Vandergrift, National Marketing Manager, FUJIFILM Medical Systems, USA
Gephardt Government ―Toshiba was pleased to participate in this important event representing CT. Toshiba, along with many others in the industry, is
Affairs committed to continuing to develop advanced low dose CT technology to improve patient safety without sacrificing diagnostic
quality. Recent innovations in CT technology are dramatically reducing radiation dose for patients, making CT imaging safer than
ever before.‖
-Rich Mather, PhD, Toshiba Medical Research Institute

―The introduction of electronic Decision Support, as it applies to clinician ordering of high-tech radiology exams, will enable the
automated use of appropriateness criteria resulting in improved clinical outcomes for patients at a lower overall cost. This event
was an incredible opportunity to show this type of IT to legislative staff and Members of Congress.‖
-Paul Tuma, Nuance Communications, Inc., Nuance Healthcare Division
―It was an absolute delight to spend time with you all and to see the incredible gains that technology and people deliver to improve
lives and outcomes. It was particularly fantastic to see Dr. Seltzer (Massachusetts’ own!) and to talk with all of the partners who
work together on behalf of your organization and the people who you serve, including the patients.‖
-Diego M. Sanchez, Health Legislative Assistant to Congressman Barney Frank (D-MA)
 July 2010
Coalition for Imaging and Bioengineering Research
CIBR Launches Legislative Campaign to
Reduce Radiation Exposure in Diagnostic Imaging
By Virginia Lathrop
The issue of radiation dose from
diagnostic imaging is drawing na-
tional attention. Earlier this year,
CIBR proactively launched the initia-
tive "Reducing Radiation Exposure
to Americans from Diagnostic Imag-
ing Studies," to address the need to
manage and reduce the amount of
ionizing radiation that patients re-
ceive from diagnostic imaging stud-
―There are many as- ies. CIBR is developing a multifacet-
pects of research op- ed national initiative to ensure that
portunities. The goal of ionizing radiation is used only when
these are generally to medically necessary and appropri-
develop federal legisla- ate, and that the radiation dose de-
tion that would provide livered meets the ALARA standard
funding to be adminis- ("as low as reasonably achievable").
tered through NIH, The goal is to develop federal legis-
AHRQ, and the FDA lation that would provide funding to
that would finance the finance the required research and
required research and development to reduce patient expo-
development that could sure to ionizing radiation. The legis-
lead to improvements lation would also provide federal
in the arenas discussed support to disseminate decision
and to also disseminate
support software to guide clinicians
best practices that
as they order imaging studies.
could be adopted in
clinical settings,
through medical device Specifically, the initiative focuses on
two areas, quality assurance and
industries and the na-
tional initiatives to information technology, and outlines
the research needed in order to
adopt electronic health
records.‖ achieve the goal of reducing radia-
tion exposure. Needed research
-Carolyn Meltzer, MD could be funded through the NIH,
Chair, Department of AHRQ, FDA, CMS or other appropri-
Radiology, Emory Uni- ate agencies. The overall approach
versity School of Medi- is to focus on improved outcomes
cine and safety while appropriately utiliz-
ing medical imaging. With appropri-
ate utilization and diagnostic proto-
cols developed with low radiation
dose, the potential benefits of imag-
ing, such as information to diagnose
disease, can far outweigh the risks.
This issue affects all stakeholders of
CIBR with each playing a pivotal role
in addressing this challenge. Patient
advocacy groups are concerned
about media reports on radiation
exposure that lead patients to de-
cline to undergo necessary imaging
procedures. CIBR’s patient advoca-
cy members must join with industry
and academia to help patients un-
derstand and evaluate imaging
benefits versus radiation risks.
Academic radiologists have a re-
sponsibility to serve as good stew-
ards of imaging technology. Their
contribution in setting the research
agenda that can lead to continued
improvement in patient outcomes
and enhanced patient safety is
seminally important. Lastly, indus-
try’s role in translating research into
product innovation is essential to
help all stakeholders. CIBR expects
to act as a facilitator and partner to
all stakeholders as it moves forward
to meet this important challenge.
―CIBR is developing a multifaceted
national initiative to ensure that
ionizing radiation is used only
when medically necessary and
appropriate, and that the radiation
dose delivered meets the ALARA
standard (as low as reasonably
achievable).‖
-Virginia Lathrop,
Policy & Programs Manager,
CIBR
In June, CIBR met with interested
Senate staff attempting to collabo-
ratively address certain challenges
and develop legislative language.
CIBR defined the radiation expo-
sure initiative by outlining a three-
phased approach: before the test,
during the test, and after the test.
First, the ―before the test‖ phase
requires the use of a decision sup-
port system to confirm medical
Page 4
www.imagingcoalition.org
necessity of the test eliminating
duplication and waste. Second, the
―during the test‖ phase requires
physicians to follow a proper testing
protocol enabling the use of dose
saving and monitoring tools. This is
aimed at ensuring optimal equip-
ment functionality as well as ade-
quate operator training. Finally, the
―after the test‖ phase calls for a na-
tional informatics database where
each patient’s radiation exposure
will be exported to an Electronic
Medical Record (EMR) and/or na-
tional database to calculate patient
specific radiation exposure.
In addition, CIBR is developing a
series of one-pagers as part of the
initiative to include information on
radiation dose and computed tomog-
raphy (CT) scanning. The one-
pagers emphasize that every medi-
cal test has potential benefits and
risks, and that patients and their
physicians need to weigh the risk-
benefit equation when determining
whether medical imaging is neces-
sary, and then which imaging proce-
dure is medically appropriate given
the clinical circumstances.
CIBR attended the FDA Public
Meeting ―Device Improvements to
Reduce Unnecessary Radiation
Exposure from Medical Imaging‖ in
March, the AAPM ―CT Dose Sum-
mit: Scan Parameter Optimization‖
in April, and the FDA Public Meeting
―Device Improvements to Reduce
the Number of Under-Doses, Over-
Doses, and Misaligned Exposures
From Therapeutic Radiation‖ in
June.
 July 2010 Page 5

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

CIBR Submits Written Comments at the First Stakeholders Meeting

of the NIH-FDA Joint Leadership Council
By Keith Kerneklian

On June 2 the Coalition for Imaging
and Bioengineering Research
(CIBR) attended the first Stakehold-
ers Meeting held by the National
Institutes of Health (NIH) and Food
and Drug Administration (FDA) Joint
Leadership Council. The Council’s
primary goal is to ensure that regula-
tory considerations form an integral
component of biomedical research
planning, and that the latest science
is integrated into the regulatory re-
view process. Chaired by Dr. Fran-
cis Collins, NIH Director, and Dr.
Margaret Hamburg, FDA Commis-
sioner, the Council consists of six
other senior representatives from
each of the two agencies.
The purpose of the meeting was to
elicit public comments on how the
NIH and FDA could better collabo-
rate to accelerate technologies to
prevent, diagnose, and treat diseas-
es. Consequently, the Joint Leader-
ship Council posed the following
questions for comments:
 What mechanisms for the sup-
port of regulatory science re-
search would be most effective
and efficient in addressing
pressing priority areas in the
translational pipeline?
 What are the priority issues that
currently need to be addressed,
e.g. clinical trial design, end-
point selection and qualifica-
tion, bioinformatics needs, to
inform on the regulatory review
process?
In response to the first question,
CIBR recommended elevating the
urgency of developing a regulatory
pathway to accelerate the rapid and
efficient clinical translation of diag-
nostic and therapeutic biomarkers.
CIBR testified that the NIH and FDA
can effectively promote promising
new diagnostic and therapeutic tech-
nological advances through coordi-
nated research and regulatory ef-
forts that bridge the gap between
discoveries and medical products.
In addition, CIBR suggested that the
NIH-FDA Joint Leadership Council,
working through the NIH, the Bi-
omarkers Consortium, and academ-
ia, undertake a focused and coordi-
nated research effort to illuminate
the process elements of a biomarker
regulatory pathway and create a
framework that will encourage bi- ―CIBR and ARR will
omarker development, validation, continue submitting
approval and dissemination. In con- testimony to the
cert with this effort, FDA would de- NIH, FDA, and
velop appropriate regulations that other appropriate
recognize the science, logistics and agencies with the
economics relevant to biomarkers. aim of raising the
The combined result would be the profile of medical
establishment of a scientific and imaging to benefit
regulatory pathway for the develop- patient care.‖
ment and commercialization of bi-
omarkers, analogous to the pathway -Keith Kerneklian,
for generic drugs and the pathway Legislative & Advo-
for ―biosimilars‖ recently authorized cacy Manager,
in the amendments to the Public CIBR
Health Service Act signed by Presi-
dent Obama earlier this year.
Furthermore, the Academy of Radi-
ology Research (ARR) submitted
written comments to the second
question, focusing on the need to
manage and reduce the amount of
ionizing radiation that patients re-
ceive from diagnostic imaging. ARR
believes that a coordinated program
of research and regulatory develop-
ment would have a significant im-
pact on decreasing radiation expo-
sure for the benefit of patients and
the United States healthcare sys-
tem.

CIBR and ARR will continue submit-

ting testimony to the NIH, FDA, and
other appropriate agencies with the
Medical research advocates attending the session includ- aim of raising the profile of medical
ed Jennifer Ayers (Executive Director, American Institute imaging to benefit patient care.
for Medical and Biological Engineering), Martha Nolan
(VP, Public Policy, Society for Women’s Health Re-
search), Keith Kerneklian (Legislative & Advocacy Man-
ager, CIBR), and James Jorkasky (Executive Director,
National Alliance for Eye and Vision Research).
 July 2010 Page 6

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

New CIBR Patient Advocacy Member Educates Women About

Non-invasive Treatment Option for Uterine Fibroids
By Tina Krall

One of CIBR’s newest patient advocacy members, Fibroid Relief, is dedicated to supporting women suffering from
uterine fibroids who seek non-invasive treatment alternatives. Fibroid Relief is committed to raising awareness about
the benefits of Focused Ultrasound and will work tirelessly to promote patient access through educational and advo-
cacy activities. Fibroid Relief’s vision is to put the power of choice in the hands of uterine fibroid sufferers.

Medical imaging is essential to treating uterine fibroids. Therefore, since its founding in 2008, Fibroid Relief has
aimed to educate women about the availability of MR-guided Focused Ultrasound treatments for uterine fibroids. To
―I appreciate the opportunity date, 6,000 women worldwide have received this non-invasive treatment option.
to join CIBR just at the right
time! The Medical Technol- Uterine fibroids are common, non-cancerous tumors of the uterus consisting of smooth muscle cells and connective
ogy Exhibit was a great tissue. At least 25 percent of women in the United States have symptoms of uterine fibroids. In fact, about 70 percent
experience to be able to of Caucasian women and more than 80 percent of African-American women have developed fibroids by the time they
provide a patient advocate are 50 years old. Many fibroids go undetected until they become symptomatic.
perspective. Getting our
collective voices heard by Fibroid Relief has touched and improved the lives of thousands of women through its educational and advocacy ac-
Members of Congress is tivities. As Tina Krall, executive director, observes, ―we’re here to raise awareness of the benefits of focused ultra-
never an easy task so when sound and to promote patient access. Our aim is to give women access to information that empowers them to make
these opportunities present sound health decisions.‖
themselves, it makes our
work easier.‖ Hailed as a breakthrough technology, MR-guided Focused Ultrasound integrates the visualization capabilities of
magnetic resonance imaging with the intense energy that is created when multiple waves of high frequency ultra-
-Tina Krall, sound are directed to a treatment site. Highly precise, it can target treatment sites as small as a grain of rice, about
Executive Director, one millimeter in diameter.
Fibroid Relief
The technology is currently approved in Europe and elsewhere for the treatment of uterine fibroids, adenomyosis and
bone metastases. In the U.S., it is approved as a therapy for uterine fibroids. Worldwide, there are 45 treatment cen-
ters using the new technology and 65 research sites investigating its use in other non-invasive procedures, in the
precise delivery of drugs and as an alternative to radiation therapy.

In addition to Fibroid Relief, the Focused Ultrasound Surgery Foundation (FUSF) provides research and fellowship
funding and engages in numerous outreach activities. Its most visible and comprehensive program, the
2nd International Symposium on MR-guided Focused Ultrasound, will be held from October 17-20, 2010 in the Wash-
ington, D.C. area. The meeting will spotlight the latest developments in pre-clinical, clinical and translational research
addressing a wide range of life-threatening and debilitating illnesses, including brain, breast, prostate, bone, pancre-
atic and liver tumors and conditions such as epilepsy, stroke, chronic pain, Parkinson's disease and essential tremor.
Information about the FUSF and the symposium can be found at www.fusfoundation.org.


 July 2010 Page 7

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

House Committee Holds Hearing on NIH

On June 15 the U.S. House of Representatives Energy and Commerce Subcommittee on Health held a hearing
titled ―NIH in the 21st Century: The Director's Perspective.‖ National Institutes of Health (NIH) Director Dr. Francis
Collins was the only witness and spoke on a variety of activities and research. Specifically related to imaging, Dr.
Collins mentioned the Alzheimer’s Disease Neuroimaging Initiative, funded by the NIA and the NIBIB; CT as a way
to assess lung cancer treatment; and NIBIB support of research consortia to examine the biological, medical, be-
havioral, and social aspects of paralysis. For both Alzheimer’s and lung cancer, Dr. Collins spoke about how imag-
ing can be used to track and evaluate the effects of treatment. He also mentioned the newly formed NIH-FDA Joint
Leadership Council and that he was working closely with FDA Commissioner Margaret Hamburg, MD, on the re-
view of biomedical research projects and clinical trials.
A theme of the hearing was the NIH research priority-setting in a time of tight budgets. Both the Subcommittee and
Dr. Collins acknowledged that limited funding may restrict research; several members asked how research areas
and projects were prioritized. Dr. Collins cited the rigorous two-level peer review process of NIH grants and listed
many factors that could go into prioritizing research, including scientific opportunity and the burden of the disease.
―In a relentless search
to find ways to slow
down or prevent Alz-
heimer’s Disease, the
CIBR Tour of NIH: Sept 21 NIH is employing a
variety of new tech-
The Coalition for Imaging and Bioengineering Research (CIBR) invites you to an educational visit of laboratories nologies and ap-
engaged in cutting-edge imaging research at the National Institutes of Health (NIH) on September 21st. proaches to identify
genes that may play a
Take advantage of this opportunity to see firsthand the extraordinary scientific opportunities that abound in bio- role in risk of late-
medical and imaging research on the NIH campus in Bethesda, Maryland. Invited to this widely attended event are onset Alzheimer’s.
legislative health staff and patient advocacy groups from the local health care community. Through various clini-
cal, neuroimaging,
The agenda will feature presentations by Bradford Wood, MD, Director of the Center for Interventional Oncology,
genetic, and fluid
and Roderic Pettigrew, PhD, MD, Director of the NIBIB.
biomarker measures
RSVP: If you are interested in attending please contact Virginia Lathrop at vlathrop@acadrad.org. to assess the se-
quence of events in
*Please note that attendance is limited due to NIH laboratory size so secure your spot in a timely manner.*
the brain which leads
from normal cognition
to Alzheimer’s Dis-
ARR Special Focus Session at RSNA 2010 ease, a public-private
partnership called the
Alzheimer’s Disease
Course: What it Takes to be an Expert Reviewer for the NIH – the Peer Review Process Demystified Neuroimaging Initia-
Date: Saturday, November 27, 2010, pm session Location: RSNA Annual Meeting, McCormick Place, Chicago tive is showing some
success in finding
Course Directors: Elizabeth Krupinski, PhD; Carolyn C. Meltzer, MD methods for early
Target Audience: Those who are already familiar with submitting grants to the NIH (but could still use a few tips) diagnosis and as-
and are interested in more details about the actual review process and how to become an expert matter reviewer sessing whether
drugs and other inter-
for the NIH.
ventions can prevent
Background: This workshop will provide attendees with a better understanding of the review process from the or delay the onset of
perspective of those who have served on review committees in order to better prepare them for submitting and Alzheimer’s Disease.‖
resubmitting proposals and to encourage them to serve as reviewers. If you think like a reviewer, you can be a
better grant writer! Although there is a significant amount of information available on how to write NIH grants and -Francis S. Collins,
how the review process works, many investigators (new and experienced) often have questions that are best an- MD, PhD, Director,
swered directly in person by those who have first-hand experience. This is particularly true for clinicians who do National Institutes of
not always have the time to search the available information. For more information please contact Virginia Lathrop Health
at vlathrop@acadrad.org.
 July 2010 Page 8

Coalition for Imaging and Bioengineering Research www.imagingcoalition.org

Member Organizations
AdMeTech Foundation
Agfa HealthCare Corporation
Alliance for Aging Research
Alpha-1 Foundation
American Association for Women Radiologists
Welcome New CIBR Members!
American Association of Physicists in Medicine
American Brain Tumor Association

Biotechnology Industry Organization

American College of Nuclear Physicians
American College of Radiology
American Diabetes Association
American Inst. for Medical and Biological Engineering Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advo-
American Institute of Ultrasound in Medicine
American Osteopathic College of Radiology cacy, business development and communications services for more than 1,200 members worldwide. BIO is
American Pain Foundation
American Registry of Radiologic Technologists
American Roentgen Ray Society
involved in the research and development of innovative healthcare, agricultural, industrial and environmental
American Society of Emergency Radiology biotechnology products. BIO also represents state and regional biotech associations, service providers to the
American Society of Neuroradiology
American Society of Radiologic Technologists industry, and academic centers. BIO’s mission is to be the champion of biotechnology and the advocate for
Association for Research in Vision and Ophthalmology
Association of Community Cancer Centers its member organizations.
Association of Educators in Imaging and Radiologic
Sciences www.bio.org
Association of University Radiologists/Association of
Program Directors in Radiology
Beth Israel Deaconess Medical Center Dept. of
Radiology
Biotechnology Industry Organization
Fibroid Relief
Blinded Veterans Association
Brain Injury Association of America Fibroid Relief is dedicated to supporting women suffering from uterine fibroids who seek non-invasive treat-
Brigham and Women’s Hospital, Dept. of Radiology
C3: Colorectal Cancer Coalition ment alternatives. Fibroid Relief is committed to raising awareness about the benefits of Focused Ultrasound
Cancer Schmancer
Case Western Reserve University , University Hospitals
Health System, Department of Radiology
and will work tirelessly to promote patient access through educational and advocacy activities. Fibroid Relief’s
Children With Diabetes Foundation
COPD Foundation
vision is to put the power of choice in the hands of uterine fibroid suffers. Fibroid Relief aims to contribute to
Cooley’s Anemia Foundation
Duke University School of Medicine, Dept. of Radiology an increased dialogue between patients, physicians, and payers so patients can make the best individual
Emory University School of Medicine, Dept of Radiology
Fibroid Relief treatment decisions without regard to reimbursement protocols and roadblocks.
First Candle
FUJIFILM Medical Systems USA, Inc.
Gammex rmi
www.fibroidrelief.org
GE Healthcare
Georgetown University Medical Center, Dept. of
Radiology
Hydrocephalus Association Parkinson’s Action Network
International & American Assns for Dental Research
International Society for Magnetic Resonance in Parkinson’s Action Network (PAN) is the unified voice of the Parkinson’s community advocating for better
Medicine
Intracranial Hypertension Research Foundation treatments and a cure. In partnership with other Parkinson’s organizations and a powerful grassroots net-
Johns Hopkins Medicine, The Russell H. Morgan
Department of Radiology and Radiological Science work, PAN educates the public and government leaders on better policies for research and an improved qual-
Juvenile Diabetes Research Foundation
Kidney Cancer Association ity of life for people living with Parkinson’s.
Lung Cancer Alliance
MaleCare www.parkinsonsaction.org
Mallinckrodt Institute of Radiology, Washington Univ
Massachusetts General Hospital, Dept. of Radiology
Mayo Clinic, Department of Radiology
Medical College of Wisconsin, Milwaukee WI, Dept. of
Radiology
Memorial Sloan-Kettering Cancer Center, Dept. of
Radiology
Mount Sinai School of Medicine, Dept. of Radiology
National Alliance for Eye and Vision Research CIBR Chair Dr. Bill Bradley, Former
National Cervical Cancer Coalition
National Spinal Cord Injury Association Democratic Leader Dick Gephardt,
National Patient Advocate Foundation
National Lung Cancer Partnership
and patient advocate Tina Krall from
Northwestern Univ, Feinberg School of Medicine, Dept.
of Radiology
Fibroid Relief at the GE display of MR-
Nuance Communications, Inc., Nuance Healthcare guided Focused Ultrasound.
Division
Parkinson’s Action Network
Philips Medical Systems
Prostate Health Education Network
Pulmonary Fibrosis Foundation
Radiological Society of North America
Radiological Society of North America Research and
Education Foundation
Siemens Medical Solutions
Society for Imaging Informatics in Medicine
Society for Pediatric Radiology
Society for Women’s Health Research
Society of Chairs of Academic Radiology Departments
CIBR welcomes new members to join us in our efforts:
Society of Computed Body Tomography and Magnetic
Resonance
Society of Interventional Radiology
SNM (formerly Society of Nuclear Medicine)  Collaborative efforts to advocate for NIH funding overall as well as for imaging research specifically
Society of Radiologists in Ultrasound
Society of Skeletal Radiology  Educational and advocacy initiatives including tours of NIH and Congressional Events
Society Thoracic Radiology
Society of Uroradiology  Joint CIBR and member sponsored Congressional educational briefings
Taking Control of your Diabetes
Toshiba Medical Systems Corporation  Opportunities to collaborate with over 100 patient groups, Academic researchers, imaging societies and industry
University of California, Los Angeles, Dept. of Radiology
Univ of California, San Diego, Department of Radiology groups
Univ of California, San Francisco, Department of
Radiology and Biomedical Imaging
University of Louisville, Department of Radiology
Univ of Michigan, Department of Radiology For more information please contact Keith Kerneklian at kkerneklian@acadrad.org.
Univ of Minnesota, Department of Radiology
Univ of North Carolina Chapel Hill, Dept. of Radiology
Univ of Pennsylvania, Department of Radiology
Univ of Texas Medical School at Houston, Department
of Diagnostic and Interventional Imaging
Univ of Utah, Department of Radiology
Univ of Washington, Department of Radiology
Von Hippel—Lindau Disease Family Alliance
Yale Univ School of Medicine, Dept. of Diagnostic
Radiology
ZERO—The Project to End Prostate Cancer